These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2738624)

  • 1. Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma.
    Friedman HS; Schold SC; Mahaley MS; Colvin OM; Oakes WJ; Vick NA; Burger PC; Bigner SH; Borowitz M; Halperin EC
    J Clin Oncol; 1989 Jul; 7(7):904-11. PubMed ID: 2738624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.
    Friedman HS; Mahaley MS; Schold SC; Vick NA; Falletta JM; Bullard DE; D'Souza BJ; Khandekar JD; Lew S; Oakes WJ
    Neurosurgery; 1986 Mar; 18(3):335-40. PubMed ID: 3703192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.
    Allen JC; Helson L
    J Neurosurg; 1981 Nov; 55(5):749-56. PubMed ID: 7310496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
    Kovnar EH; Kellie SJ; Horowitz ME; Sanford RA; Langston JW; Mulhern RK; Jenkins JJ; Douglass EC; Etcubanas EE; Fairclough DL
    J Clin Oncol; 1990 Feb; 8(2):330-6. PubMed ID: 2153766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of recurrent medulloblastoma to low-dose oral etoposide.
    Ashley DM; Meier L; Kerby T; Zalduondo FM; Friedman HS; Gajjar A; Kun L; Duffner PK; Smith S; Longee D
    J Clin Oncol; 1996 Jun; 14(6):1922-7. PubMed ID: 8656261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
    Corden BJ; Strauss LC; Killmond T; Carson BS; Wharam MD; Kumar AJ; Piantadosi S; Robb PA; Phillips PC
    J Neurooncol; 1991 Aug; 11(1):57-63. PubMed ID: 1919647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of oral melphalan in recurrent primary brain tumors.
    Chamberlain MC; Prados MD; Silver P; Levin VA
    Am J Clin Oncol; 1988 Feb; 11(1):52-4. PubMed ID: 2829615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
    Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
    Graham ML; Herndon JE; Casey JR; Chaffee S; Ciocci GH; Krischer JP; Kurtzberg J; Laughlin MJ; Longee DC; Olson JF; Paleologus N; Pennington CN; Friedman HS
    J Clin Oncol; 1997 May; 15(5):1814-23. PubMed ID: 9164190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II evaluation of thiotepa in pediatric central nervous system malignancies.
    Heideman RL; Packer RJ; Reaman GH; Allen JC; Lange B; Horowitz ME; Steinberg SM; Gillespie A; Kovnar EH; Balis FM
    Cancer; 1993 Jul; 72(1):271-5. PubMed ID: 8508417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
    Kieran MW; Chisholm J; Casanova M; Brandes AA; Aerts I; Bouffet E; Bailey S; Leary S; MacDonald TJ; Mechinaud F; Cohen KJ; Riccardi R; Mason W; Hargrave D; Kalambakas S; Deshpande P; Tai F; Hurh E; Geoerger B
    Neuro Oncol; 2017 Oct; 19(11):1542-1552. PubMed ID: 28605510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with pineoblastoma with high dose cyclophosphamide.
    Ashley DM; Longee D; Tien R; Fuchs H; Graham ML; Kurtzberg J; Casey J; Olson J; Meier L; Ferrell L; Kerby T; Duncan-Brown M; Stewart E; Colvin OM; Pipas JM; McCowage G; McLendon R; Bigner DD; Friedman HS
    Med Pediatr Oncol; 1996 Jun; 26(6):387-92. PubMed ID: 8614374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
    Kadota RP; Mahoney DH; Doyle J; Duerst R; Friedman H; Holmes E; Kun L; Zhou T; Pollack IF
    Pediatr Blood Cancer; 2008 Nov; 51(5):675-8. PubMed ID: 18623206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
    Gururangan S; McLaughlin C; Quinn J; Rich J; Reardon D; Halperin EC; Herndon J; Fuchs H; George T; Provenzale J; Watral M; McLendon RE; Friedman A; Friedman HS; Kurtzberg J; Vredenbergh J; Martin PL
    J Clin Oncol; 2003 Jun; 21(11):2187-91. PubMed ID: 12775745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Gajjar A; Pizer B
    Pediatr Blood Cancer; 2010 Apr; 54(4):649-51. PubMed ID: 20146223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide treatment of an adult with a relapsing medulloblastoma.
    Durando X; Thivat E; Gilliot O; Irthum B; Verrelle P; Vincent C; Bay JO
    Cancer Invest; 2007 Sep; 25(6):470-5. PubMed ID: 17882660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
    Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy.
    Sterba J; Pavelka Z; Andre N; Ventruba J; Skotakova J; Bajciova V; Bronisova D; Dubska L; Valik D
    Pediatr Blood Cancer; 2010 Apr; 54(4):616-7. PubMed ID: 19967772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
    Stewart CF; Iacono LC; Chintagumpala M; Kellie SJ; Ashley D; Zamboni WC; Kirstein MN; Fouladi M; Seele LG; Wallace D; Houghton PJ; Gajjar A
    J Clin Oncol; 2004 Aug; 22(16):3357-65. PubMed ID: 15310781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.